Results 21 to 30 of about 152,484 (372)

Cannabinoids

open access: yesAsian Journal of Pharmaceutical Research and Health Care, 2022
Cannabidiol industrialization is expected to reach $20 billion in sales by 2024 due to a sudden rise in scientific interest in marijuana (cannabis) and its therapeutic potential. Cannabis has been utilized for thousands of years in both medicine and science.
Nicholas T. Lappas, Courtney M. Lappas
  +4 more sources

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study

open access: yesBMC Pediatrics, 2018
Background Initial studies suggest pharmaceutical grade cannabidiol (CBD) can reduce the frequency of convulsive seizures and lead to improvements in quality of life in children affected by epileptic encephalopathies.
Darren Reithmeier   +14 more
doaj   +1 more source

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

open access: yesFrontiers in Psychiatry, 2022
IntroductionSynthetic cannabinoid receptor agonists (SCRAs) are a diverse class of new psychoactive substances that have been associated with multiple instances and types of toxicity. Some SCRAs appear to carry a greater toxicological burden than others,
Richard C. Kevin   +13 more
doaj   +1 more source

Cannabinoid Receptor Involvement in Stress-Induced Cocaine Reinstatement: Potential Interaction with Noradrenergic Pathways [PDF]

open access: yes, 2012
This study examined the role of endocannabinoid signaling in stress-induced reinstatement of cocaine seeking and explored the interaction between noradrenergic and endocannabinergic systems in the process.
Hillard, Cecilia J.   +6 more
core   +2 more sources

Endocannabinoid-related compounds in gastrointestinal diseases [PDF]

open access: yes, 2018
The endocannabinoid system (ECS) is an endogenous signalling pathway involved in the control of several gastrointestinal (GI) functions at both peripheral and central levels.
Alessandra, D'Alessandro   +7 more
core   +1 more source

The evolution and comparative neurobiology of endocannabinoid signalling [PDF]

open access: yes, 2012
CB(1)- and CB(2)-type cannabinoid receptors mediate effects of the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide in mammals. In canonical endocannabinoid-mediated synaptic plasticity, 2-AG is generated postsynaptically by diacylglycerol ...
Devane W. A.   +4 more
core   +1 more source

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products

open access: yesInternational Journal of Molecular Sciences, 2020
Cannabinoid receptors (CB1 and CB2), as part of the endocannabinoid system, play a critical role in numerous human physiological and pathological conditions.
Dongchen An   +3 more
semanticscholar   +1 more source

Cannabinoid Hyperemesis Syndrome [PDF]

open access: yes, 2015
Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent ...
Heise, Lynn
core   +2 more sources

Cannabinoid Ligands Targeting TRP Channels

open access: yesFrontiers in Molecular Neuroscience, 2019
Transient receptor potential (TRP) channels are a group of membrane proteins involved in the transduction of a plethora of chemical and physical stimuli.
Chanté Muller, P. Morales, P. Reggio
semanticscholar   +1 more source

Ictal vocalizations in the Scn1a+/− mouse model of Dravet syndrome

open access: yesEpilepsia Open, 2023
Objective Ictal vocalizations have shown diagnostic utility in epilepsy patients. Audio recordings of seizures have also been used for seizure detection. The present study aimed to determine whether generalized tonic–clonic seizures in the Scn1a+/− mouse
Lyndsey L. Anderson   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy